HJ-CTC George, South Africa Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2010
NCT01113281
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

HJ-CTC George, RSA (Statistics & Report)

Active Ingredients

Drugs in Phase 2 Trials (1)

bacille calmette-guerin (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Tuberculosis (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 1